Fundraising Fox

Marko Tvrdic

Founder

Founder at Exin Therapeutics

San Francisco Bay Area

FoundedExin Therapeutics · YC

About

Marko Tvrdic is cofounder and COO at Exin Therapeutics, a company focused on therapeutic development. He holds an MSc and PhD from Oxford and has research experience across molecular biology, neuroscience disciplines including retinal disorders, circadian biology, and neurodevelopment, with prior exposure to venture capital.

LinkedIn ↗X / Twitter ↗
Latest on 𝕏

Marko Tvrdić @markotvrdic

Check out what I’ve been up to in 1st year of my PhD with @Ox_DTP. I’ll be showing some early work on neural representations of learning. Together with @OrsiFolsz , @HuriyeAtilgan and @ArminLak. PS02-26PM-226. #FENS2024

Jun 22, 2024 · ♥ 17 · ⇄ 4

Founder at Exin TherapeuticsYC W25

Intro paths

YC

Marko went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.

GP

Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Exin Therapeutics's batch and knows the company first-hand. YC profile ↗

→

In turn, Marko can intro founders to Exin Therapeutics's investors below.

Exin Therapeutics's investors · 2

468 CapitalY Combinator

Co-founders at Exin Therapeutics

GOGabriel Ocana Santero
Gabriel Ocana SanteroFounder
IA
Ivan Alex Priela LazarteExecutive Officer, Director

Experience

  1. Exin Therapeutics (YC W25)Co-Founder & COOcurrent2025 — presentSan Francisco, California, United States
  2. University of OxfordDPhil student in Neuroscience2022 — 2025
  3. University of OxfordDPhil - 2nd rotation project2023
  4. University of OxfordDPhil - 1st rotation project2023
  5. University of OxfordMSc Student2021 — 2022
  6. Creator FundAssociate student investment partner2024London Area, United Kingdom
  7. Creator FundVenture fellow2023 — 2024London Area, United Kingdom
  8. The University of EdinburghUndergraduate Researcher2021Edinburgh, Scotland, United Kingdom
  9. University of SplitNeuroscientist2019Split, Croatia
  10. MedILSMolecular Biologist2018Split, Croatia

Education

  1. University of OxfordDPhil in Neuroscience, Interdisciplinary Bioscience DTP
  2. University of OxfordMaster's by Research, Neuroscience
  3. The University of EdinburghBachelor of Science, Neuroscience

Same school

Also attended University of Oxford745

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 739 more

Also attended The University of Edinburgh147

Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiKevin JohnsonInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalEmily PawlakVice President at Volition CapitalTom FergusonFounder and Managing Partner at BURNT ISLAND VENTURES

+ 141 more

Shared employers

Also worked at Exin Therapeutics (YC W25)1

Gabriel Ocana SanteroFounder at Exin Therapeutics

Also worked at University of Oxford69

Tess van StekelenburgPartner at Lux CapitalFrancesco MonacaInvestor at Giant Ventures Global LlpDenise XifaraInvestor at Mercuri.vcLirui DingPrincipal at TRANSCENDAna FernandezInvestment Associate at Nauta CapitalVictoria FähInvestment Manager, Future Content Fund at IPR.VC

+ 63 more

Also worked at Creator Fund31

Naseem MoumeneVice President at NorthzoneHugo SilvaPartner at Pi LabsJai TaylorInvestor at Blue Wire CapitalMaddy BergenProgram Manager at CV LabsHenry Lane FoxChief Executive Officer, Founder at Founders FactoryOlivia BrooksHead of Investments at Founders Factory

+ 25 more

Also worked at The University of Edinburgh18

Alex RendónInvestment Associate at BuenTrip VenturesLucia Rodriguez LacasaInvestor at AlbionVCThilo SchroederManaging Partner at Nextech InvestJonathan Fajardo CortesPrincipal at imec.xpandMoritz MüllerInvestment Associate at imec.xpandJen DaviesChief of Staff at The 51 Ventures

+ 12 more